Change - Announcement of Cessation::Change Announcement of Cessation
Issuer & Securities
TIANJIN ZHONG XIN PHARM GROUP
TIANJIN ZHONG XIN PHARM GROUP - CNE100000924 - T14
Change - Announcement of Cessation
Date &Time of Broadcast
Announcement Sub Title
Change Announcement of Cessation
Submitted By (Co./ Ind. Name)
Secretary to the Board
Effective Date and Time of the event
Description (Please provide a detailed description of the event in the box below)
Announcement of Cessation of Independent Director
Name Of Person
Mr Wong Gang
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
Mr Wong Gang had ceased to be an independent director of the Company as of 15 May 2014, as he did not stand for re-election as a director at the Company s annual general meeting held on 15 May 2014.
Mr Wong Gang s cessation as an independent director is in compliance with Article 14 under the Guidelines of Filing and Training for Independent Director in the Listed Companies promulgated by the Shanghai Stock Exchange in 2010, where it is stated that an independent director cannot serve on the board of a listed company for more than six years.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director, Chairman of Remuneration Committee and a member of the Audit Committee.
Role and responsibilities
Duties as an Independent Director of the Board, Chairman of Remuneration Committee and a member of the Audit Committee.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
Past (for the last 5 years)
Fujian Zhenyun Plastics Industry Co., Ltd
(a) China Animal Healthcare Limited (b) Tianjin Zhongxin Pharmaceutical Group Corporation Limited (c) Renewable Energy Asia Group Limited (d) JEP Holdings Ltd (e) Bowsprit Capital Corporation Limited